Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PD-L1 expression, BRAF and TERT mutation in a cohort of aggressive thyroid cancers: case series from a single-centre experience.

Journal of endocrinological investigation - 1 Oct 2023

Monti E, Gay S, Dono M, Giusti M, Pigozzi S, De Luca G, Anselmi G, Mora M, Spina B, Minuto M N, Albertelli M, Gatto F, Ferone D

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Mutation
Share to Proto-Oncogene Proteins B-raf

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Telomerase

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 36933169
DOI: 10.1007/s40618-023-02063-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PD-L1 expression, BRAF and TERT mutation in a cohort of aggressive thyroid cancers: case series from a single-centre experience.PMID 36933169Read ↗

Prognostic Characterization of Papillary Thyroid Carcinoma: Insights into the Role of PD-L1 and Mutational Landscape in Disease Aggressiveness and OutcomeSemantic proximity Read ↗

Prognostic characterization of papillary thyroid carcinoma: Insights into the role of PD-L1 and mutational landscape in disease aggressiveness and outcome.Semantic proximity Read ↗

PD-L1 expression in rare and aggressive thyroid cancers: A preliminary investigation for a role of immunotherapy.Semantic proximity Read ↗

BRAF and TERT promoter mutations: clinical application in thyroid cancer.Semantic proximity Read ↗

Emerging Biomarkers in Thyroid Practice and ResearchSemantic proximity Read ↗

Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes.Semantic proximity Read ↗

Clinical Characteristics and Prognostic Markers of Aggressive Subtypes of Thyroid Cancer: A Retrospective Chart Review StudySemantic proximity Read ↗

PD-L1 Expression and Its Modulating Factors in Anaplastic Thyroid Carcinoma: A Multi-institutional Study.Semantic proximity Read ↗

TERT Promoter and BRAF V600E Mutations in Papillary Thyroid Cancer: A Single-Institution Experience in KoreaSemantic proximity Read ↗

Molecular Profile of Locally Aggressive Well Differentiated Thyroid Cancers.Semantic proximity Read ↗

TERT promoter mutations and long-term survival in patients with thyroid cancer.Semantic proximity Read ↗

How do BRAFV600E and TERT promoter mutations interact with the ATA and TNM staging systems in thyroid cancer?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.